Compare ONEW & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONEW | PRQR |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.4M | 250.7M |
| IPO Year | 2020 | 2014 |
| Metric | ONEW | PRQR |
|---|---|---|
| Price | $10.82 | $2.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $19.00 | $8.14 |
| AVG Volume (30 Days) | 196.6K | ★ 687.0K |
| Earning Date | 01-29-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,872,334,000.00 | $18,859,556.00 |
| Revenue This Year | $2.23 | N/A |
| Revenue Next Year | $3.55 | $19.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.63 | N/A |
| 52 Week Low | $10.14 | $1.07 |
| 52 Week High | $21.00 | $3.10 |
| Indicator | ONEW | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 41.32 | 42.91 |
| Support Level | $10.14 | $1.91 |
| Resistance Level | $10.82 | $2.31 |
| Average True Range (ATR) | 0.49 | 0.17 |
| MACD | 0.11 | -0.02 |
| Stochastic Oscillator | 30.41 | 21.74 |
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.